- Clinical Efficacy and Safety of Naftopidil Treatment for Patients with Benign Prostatic Hyperplasia and Hypertension: A Prospective, Open-Label Study
-
Chung MS, Yoon BI, Lee SH
- KMID: 2419087
- Yonsei Med J.
- 2017 Jul;58(4):800-806.
- doi: 10.3349/ymj.2017.58.4.800
PURPOSE: To investigate the efficacy and safety of naftopidil for benign prostatic hyperplasia (BPH) patients, mainly focusing on changes in blood pressure (BP). MATERIALS AND METHODS: Of a total of 118... -
- CITED
-
- Close
- SHARE
-
- Close
- Is Tamsulosin 0.2 mg Effective and Safe as a First-Line Treatment Compared with Other Alpha Blockers?: A Meta-Analysis and a Moderator Focused Study
-
Shim SR, Kim JH, Chang IH, Shin IS, Hwang SD, Kim KH, Yoon SJ, Song YS
- KMID: 2374047
- Yonsei Med J.
- 2016 Mar;57(2):407-418.
- doi: 10.3349/ymj.2016.57.2.407
PURPOSE: Tamsulosin 0.2 mg is used widely in Asian people, but the low dose has been studied less than tamsulosin 0.4 mg or other alpha blockers of standard dose. This... -
- CITED
-
- Close
- SHARE
-
- Close
